Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.

Diav-Citrin O, Shechtman S, Halberstadt Y, Finkel-Pekarsky V, Wajnberg R, Arnon J, Di Gianantonio E, Clementi M, Ornoy A.

Reprod Toxicol. 2011 May;31(4):540-5. doi: 10.1016/j.reprotox.2011.02.008. Epub 2011 Feb 18.

PMID:
21338666
2.

[Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].

Lonati C, Morganti A.

Pediatr Med Chir. 2009 May-Jun;31(3):137-9. Italian. No abstract available.

PMID:
19739495
3.

Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.

Polifka JE.

Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):576-98. doi: 10.1002/bdra.23027. Epub 2012 Jul 17. Review.

PMID:
22807387
4.

Angiotensin II receptor blockers in pregnancy: a report of five cases.

Gersak K, Cvijic M, Cerar LK.

Reprod Toxicol. 2009 Jul;28(1):109-12. doi: 10.1016/j.reprotox.2009.02.004. Epub 2009 Feb 24.

PMID:
19491003
5.

Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.

Enzensberger C, Eskef K, Schwarze A, Faas D, Axt-Fliedner R.

Ultraschall Med. 2012 Oct;33(5):493-6. Epub 2011 May 31. Review. No abstract available.

PMID:
21630188
6.
7.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.

Pucci M, Sarween N, Knox E, Lipkin G, Martin U.

Expert Rev Clin Pharmacol. 2015 Mar;8(2):221-31. doi: 10.1586/17512433.2015.1005074. Epub 2015 Jan 22. Review.

PMID:
25612630
8.

Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.

Walfisch A, Al-maawali A, Moretti ME, Nickel C, Koren G.

J Obstet Gynaecol. 2011 Aug;31(6):465-72. doi: 10.3109/01443615.2011.579197. Review.

PMID:
21823839
9.
10.

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.

J Clin Psychiatry. 2005 Mar;66(3):317-22.

PMID:
15766297
11.

Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.

Bos-Thompson MA, Hillaire-Buys D, Muller F, Dechaud H, Mazurier E, Boulot P, Morin D.

Ann Pharmacother. 2005 Jan;39(1):157-61. Epub 2004 Dec 8. Review. Erratum in: Ann Pharmacother. 2005 Feb;39(2):389.

PMID:
15590878
12.

Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?

Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK.

Diabetes Obes Metab. 2010 Dec;12(12):1072-8. doi: 10.1111/j.1463-1326.2010.01298.x.

PMID:
20977578
13.

Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.

Schaefer C.

Birth Defects Res A Clin Mol Teratol. 2003 Aug;67(8):591-4.

PMID:
14632309
14.

Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Boix E, Zapater P, Picó A, Moreno O.

J Endocrinol Invest. 2005 Dec;28(11):1029-31.

PMID:
16483184
15.

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA.

N Engl J Med. 2006 Jun 8;354(23):2443-51.

16.

[Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].

Partosch F, Stahlmann R.

Med Monatsschr Pharm. 2011 Oct;34(10):358-62. Review. German. No abstract available.

PMID:
22010419
17.

Angiotensin converting enzyme inhibitors in pregnancy.

Mastrobattista JM.

Semin Perinatol. 1997 Apr;21(2):124-34. Review.

PMID:
9201818
18.
19.

Antihypertensive drugs and the risk of prostate cancer.

Morote J, Planas J.

Eur Urol. 2011 Dec;60(6):1309-10. doi: 10.1016/j.eururo.2011.09.009. Epub 2011 Sep 17. No abstract available.

PMID:
21962717
20.
Items per page

Supplemental Content

Write to the Help Desk